Clinical Trial to Assess the Safety and Efficacy of Aztreonam for Inhalation Solution (AZLI) in patients with Cystic Fibrosis (CF) and Chronic Burkholderia Species Infection

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-011740-19

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to evaluate the safety and efficacy of continuous AZLI treatment in subjects with CF and Burkholderia spp. infection in the airways.


Critère d'inclusion

  • Cystic Fibrosis subjects with chronic Burkholderia spp. infection of the airways

Liens